A prospective cohort study of hypofractionated radiotherapy using 60Gy in 20 fractions for prostate cancer with IMRT/IGRT

A prospective cohort study of hypofractionated radiotherapy using 60Gy in 20 fractions for prostate cancer with IMRT/IGRT - A prospective cohort study of hypofractionated RT for prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035606

Enrollment

Registered

2019-01-22

Start date

2019-01-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Primary adenocarcinoma of the prostate 2) T1c-T3bN0M0 (UICC TNM 8th Edition) 3) Age >= 20 years old 4) ECOG-PS 0-2 5) No previous pelvic radiotherapy 6) Fiducial marker guided prostate radiotherapy can be used 7) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Treated with brachytherapy 2) Received anti-androgen therapy for more than 1 year 3) After radical prostatectomy 4) Inflammatory bowel disease 5) Bilateral total hip arthroplasty 6) Synchronous or metachronous malignancies 7) Patients who attending physicians consider to be inappropriate due to other reasons mentioned above

Design outcomes

Primary

Measure	Time frame
Five-year biochemical relapse-free survival	—

Countries

Japan

Contacts

Public ContactKoyo Kikuchi

Iwate medical university Department of radiation oncology

kikuchi@iwate-med.ac.jp019-613-7111

Outcome results